Evidence map›Paper›PMID 41425916›Full record

ArticleFrontiers in aging neuroscience2025

Assessing neurocognitive functioning among adults ageing with and without HIV at the Kenyan Coast: measurement issues and correlates.

Patrick N Mwangala, Carophine Nasambu, Ryan G Wagner, Mihaela Duta, Gaia Scerif, Charles R Newton, Amina Abubakar

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Patrick N MwangalaInstitute for Human Development, Aga Khan University, Nairobi, Kenya.
Carophine NasambuCentre for Geographic Medicine Research Coast, Kenya Medical Research Institute (KEMRI), Kilifi, Kenya.
Ryan G WagnerMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Mihaela DutaOxford Research Software Engineering Group, Doctoral Training Centre, University of Oxford, Oxford, United Kingdom.
Gaia ScerifOxford Research Software Engineering Group, Doctoral Training Centre, University of Oxford, Oxford, United Kingdom.
Charles R NewtonInstitute for Human Development, Aga Khan University, Nairobi, Kenya.
Amina AbubakarInstitute for Human Development, Aga Khan University, Nairobi, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cognitive impairment is one of the most prevalent complications of HIV infection, with significant medical and functional impacts. However, valid, and reliable assessment tools are lacking for the newly emergent ageing population of people living with HIV (PLWH) in many parts of sub-Saharan Africa (SSA), including Kenya. Without these tools, critical intervention opportunities, e.g., psychoeducation, treatment and additional support, are missed. To bridge this gap in Kenya, we adapted the Oxford Cognitive Screen Plus (OCSPlus), a tablet-based cognitive assessment tool designed for low-literacy settings, with adults ageing with HIV ≥ 50 years and their uninfected peers. This study examines the acceptability, reliability, and validity of the OCSPlus tool among older Kenyan adults and provides an initial understanding of the cognitive performance of these adults (by HIV status) and the biopsychosocial factors associated with their cognitive performance. Methods: In a cross-sectional sample of 440 older adults (257 living with HIV), we administered the OCSPlus tool alongside the Raven's Standard Progressive Matrices (RSPM), the International HIV Dementia Scale (IHDS), and health and sociodemographic assessments. Results: There was a high level of acceptability of OCSPlus by participants and test administrators. OCSPlus demonstrated good test-retest reliability. Acceptable correlations between individual OCSPlus sub-tasks and conventional tests (RSPM and IHDS) were also observed for convergent validity. Regarding cognitive performance, older adults living with HIV (OALWH) presented with significantly lower scores on language (picture naming task), executive function, and the IHDS overall score compared to their uninfected peers. However, OALWH performed significantly better on memory domain (orientation, word encoding and word recall tasks), non-verbal intelligence and processing speed. There were no differences in attention domain. Cognitive performance as assessed by OCSPlus was significantly associated with behavioural and lifestyle factors (physical activity, sleeping difficulties, obesity, and sexual activity), sociodemographic factors (age, sex, educational status, household income, household size and asset index), medical or treatment factors (self-reported urinary incontinence, hearing problems, history of TB, seeking services of traditional healers, antiretroviral therapy (ART) regimen change, being on 3rd line ART treatment) and psychosocial factors including ageism and food insecurity. Conclusion: We demonstrated the feasibility of OCSPlus administration by trained lay persons, its acceptability, and preliminary reliability and validity among low-literacy older adults on the Kenyan coast. Mean cognitive scores were mixed across the two groups. Cognitive performance was associated with several biopsychosocial factors spanning behavioural/lifestyle, sociodemographic, psychosocial, medical and treatment factors. Further validation studies and epidemiological research are needed to understand better the utility of OCSPlus and the cognitive function of these adults.

Indexed as

cognitiondeterminantsHIVKenyaOCSPlusolder adults

Identifiers

PMID41425916
PMCPMC12711723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.